EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 G

Ensembl ID : ENSOTSG00005031728
Gene Symbol: CACNA1G
1 Cross references
189 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOTSG00005035060
Gene Symbol: CNR1
3 Cross references
128 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOTSG00005009784
Gene Symbol: CNR1
1 Cross references
144 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOTSG00005022625
Gene Symbol: CNR1
1 Cross references
129 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSOTSG00005023719
Gene Symbol: CNR2
1 Cross references
184 Possible Orthologues:

Cannabinoid Receptor 2-Like

Ensembl ID : ENSOTSG00005034517
Gene Symbol: LOC112245035
3 Cross references
184 Possible Orthologues:

Cannabinoid Receptor 2-Like

Ensembl ID : ENSOTSG00005030388
Gene Symbol: LOC112245035
3 Cross references
184 Possible Orthologues:

Cannabinoid Receptor Type 1a

Ensembl ID : ENSOTSG00005022007
Gene Symbol: LOC112217499
3 Cross references
144 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSOTSG00005025839
Gene Symbol: CA12
1 Cross references
211 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSOTSG00005033181
Gene Symbol: LOC112265504
3 Cross references
190 Possible Orthologues:

Carbonic Anhydrase 5b, Mitochondrial-Like

Ensembl ID : ENSOTSG00005028654
Gene Symbol: LOC112252260
3 Cross references
225 Possible Orthologues:

Carbonic Anhydrase 7-Like

Ensembl ID : ENSOTSG00005033126
Gene Symbol: LOC112232238
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).